1. Talia, Marianna, Cirillo, Francesca, Spinelli, Asia, Maggiolini, Marcello, Lappano, Rosamaria. 2023. The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells. In Journal of experimental & clinical cancer research : CR, 42, 164. doi:10.1186/s13046-023-02747-5. https://pubmed.ncbi.nlm.nih.gov/37434266/
2. Wainberg, Michael, Forde, Natalie J, Mansour, Salim, Hawco, Colin, Tripathy, Shreejoy J. 2024. Genetic architecture of the structural connectome. In Nature communications, 15, 1962. doi:10.1038/s41467-024-46023-2. https://pubmed.ncbi.nlm.nih.gov/38438384/
3. Ding, Li, Getz, Gad, Wheeler, David A, Meyerson, Matthew, Wilson, Richard K. . Somatic mutations affect key pathways in lung adenocarcinoma. In Nature, 455, 1069-75. doi:10.1038/nature07423. https://pubmed.ncbi.nlm.nih.gov/18948947/
4. Zhang, Jubiao, Chen, Yang, Yan, Lihong, Yang, Fen, Li, Juxue. . EphA3 deficiency in the hypothalamus promotes high-fat diet-induced obesity in mice. In Journal of biomedical research, 37, 179-193. doi:10.7555/JBR.36.20220168. https://pubmed.ncbi.nlm.nih.gov/37013864/
5. Lahtela, Jenni, Pradhan, Barun, Närhi, Katja, Brown, Arthur, Verschuren, Emmy W. 2015. The putative tumor suppressor gene EphA3 fails to demonstrate a crucial role in murine lung tumorigenesis or morphogenesis. In Disease models & mechanisms, 8, 393-401. doi:10.1242/dmm.019257. https://pubmed.ncbi.nlm.nih.gov/25713296/
6. London, Max, Gallo, Eugenio. 2020. Critical role of EphA3 in cancer and current state of EphA3 drug therapeutics. In Molecular biology reports, 47, 5523-5533. doi:10.1007/s11033-020-05571-8. https://pubmed.ncbi.nlm.nih.gov/32621117/
7. Wang, Yong, Xuan, Zhuoqi, Wang, Baocheng, Wang, Jiandong, Sun, Yueming. 2018. EphA3 Downregulation by Hypermethylation Associated with Lymph Node Metastasis and TNM Stage in Colorectal Cancer. In Digestive diseases and sciences, 64, 1514-1522. doi:10.1007/s10620-018-5421-9. https://pubmed.ncbi.nlm.nih.gov/30560328/
8. Wu, Ruiqin, Wang, Hongtao, Wang, Jian, Li, Shanhu, Zhou, Jianguang. 2014. EphA3, induced by PC-1/PrLZ, contributes to the malignant progression of prostate cancer. In Oncology reports, 32, 2657-65. doi:10.3892/or.2014.3482. https://pubmed.ncbi.nlm.nih.gov/25231727/